Board & Leadership Recent board developments and leadership changes signal evolving strategic directions and potential new sponsorships or partnerships. Engage with incoming board member Michael Swinford and monitor leadership transitions for introductions to decision makers overseeing strategic initiatives and funding.

Strategic Acquisitions Notable acquisition of AlterG and ongoing exoskeleton technology development indicate a growth and integration mindset. Explore cross-sell opportunities with hospitals, rehab centers, and insurers that could leverage an expanded product suite for gait training, mobility aids, and rehabilitation programs.

Product Evolution Continued focus on next generation exoskeletons and wearable robotics suggests demand for advanced therapy devices. Position for clinical adoption partnerships, pilot programs, and reimbursement-ready solutions with rehabilitation networks seeking cutting-edge mobility tech.

Market Positioning Operating in stroke rehabilitation and spinal cord injury with mid-market scale indicates room to expand into adjacent markets and geographies. Target mid to large healthcare systems, specialty rehab centers, and durable medical equipment distributors looking to augment their robotic device portfolios.

Financial Signals Revenue range and modest funding indicate a growth-stage profile with potential for collaborations around clinical trials, data collaboration, and joint go-to-market initiatives. Propose value-bearing partnerships, joint marketing, and sponsored studies to accelerate adoption.